Hepatitis Flashcards

1
Q

how does viral replication of hepatitis C occur?

A

it has SUPER high levels of viral replication

it is highly error prone, and there is a “cloud” of quasispecies

it only exists in the cytoplasm and does not get integrated into nucleus/genome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how does HCV transmit?

what about vertical transmission?

what type of virus is it?

A

this is a single stranded RNA virus

parenteral transmission is most frequent
- 90% of new infections due to injecting drugs

there is a risk of sexual transmission, but it is quite low

the risk of vertical transmission is about 4% if mother has active replication (PCR demonstrates some virus in the blood)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

is there any role for testing neonates for HCV? (if mother +)

A

not really, because there will be some transmission of the antibodies, therefore it will be falsely positive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the natural history of HCV infection?

A

about 25% will spontaneously clear the virus on first infection

the rest will have chronic infection

about 15% of total infected will develop cirrhosis after about 20 years

total lifetime risk is about 40%

only about 5% of the cirrhotics develop liver failure or cancer EACH YEAR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

how does hep c kill hepatocytes?

A

it isn’t directly toxic.

it seems to lead to CTL killing of the cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the role of liver biopsy in Hep C?

A

it is no longer a pre-req for treatment

it can be used to determine prognosis and relative need for treatment perhaps?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is the goal of treatment in Hep C?

A

the goal is cure, which is actually “sustained virologic response”

this is no detectable disease 6 months after cessation of treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are some factors that favour successful treatment?

A
genotype 2, 3
early stage disease
IL28b cc genotype
low viral load
young, female, while, thing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the IL28b genotype?

A

this is a genotype that predicts response to treatment

the C/C genotype is best, and this was shown to be the same with different ethnicities

T/T is bad news though

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

how do we treat Hep C?

A

genotype 1 and 4: 48 weeks of Peg-interferon and ribavirin and a DAA (hep c protease inhibitor - teleprevir and boceprevir)

genotype 2 and 3: 24 weeks of Peg-IF and ribavirin. 48 weeks if already cirrhotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is peg-interferon?

A

the PEG stands for polyethylene glycol

it slows the absorption and metabolism

the interferon is the same drug as that released by immune system (LLs).

it has some sort of anti-viral action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is ribavirin?

A

this is a nucleoside analogue

it doesn’t work as monotherapy

it is a potent teratogen - double contraception is required

it can cause haemolysis. this is important. is dose dependent

MOST COMMON SIDE EFFECT IS HAEMOLYTIC ANAEMIA! AAAAAHHHHH! DON’T FORGET THIS AGAIN!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the new agent sofobuvir?

A

this is an inhibitor of HCV RNA-dependent RNA polymerase

this is a super dooper effective anti-Hep C agent and has now been recommended as first line in the US

(not yet available in Australia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is the recurrence rate of Hep C in liver transplantation?

A

always

in 5 years post OLT 30 - 40% will have progressive liver disease

(this is a bad disease to have in the OLT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is the treatment protocol in HCV/HIV coinfection?

A

step 1 is to optimise HAART first, then treat the HCV

the HCV liver disease will progress rapidly and needs aggressive treatment

liver disease is actually the leading cause of mortality in these co-infected patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what type of virus is HBV?

what makes cure difficult?

is it more or less carcinogenic than other hep viruses?

A

it is a double stranded DNA virus

it has a high level of viraemia when active

it is super dooper infective

it integrates into the host genome making cure difficult

it is significantly more carcinogenic than other hepatitis viruses. It can cause cancer pre-cirrhosis c.f. HCV

17
Q

what are the molecular pathogenetics of Hep B?

A

HBV isn’t usually cytopathic to hepatocytes

the HBeAg (the precore antigen) is essential for establishing persistent infection. This means that at the start of infection this MUST be present. Perhaps this suppresses the immune response

the liver disease is probably due to host immune responses

the HBV polymerase lacks proof reading function

18
Q

what are the modes of transmission of HBV?

does age of infection make a difference to chronicity of infection?

A

perinatal in areas of high endemicity

sexual contact

blood products

organ transplant

unknown

IVDU

if someone is infected age 2 years = 5% chronic HBV

19
Q

what are the treatment options in Hep B?

how do you choose between them?

A

immune modulating based treatment, using PEG-interferon

  • for interferon to work, there needs to be active hepatitis - therefore, the ALT has to be elevated
  • however, a severe flare can occur following introduction of interferon

OR

nucleoside analogues, primarily entecavir and tenofovir

20
Q

why are we worried about viral resistance to entecavir and tenofovir?

A

these drugs both target DNA pol

that means that, theoretically, mutations could occur in a single area, that could lead to resistance.

however, this has yet to occur (as fair as we know)

21
Q

why does Hep B treatment with nucleoside analogues need to be life long?

A

it’s because of the persistence of cccDNA in the infected cell’s nucleus

this is a circular bit of DNA that can be a template for future infection. Because it’s just chillin’ in the cell, it’s impossible for the body to completely eliminate it

this is less of an issue with interferon because there’s no single drug target (it just sort of stimulates an anti-viral activity in the body - i dunno, eh)

22
Q

what is the risk of vertical transmission in HBV?

how do we treat/prevent?

A

this is a seriously infective virus. The risk is very high - around 90% if eAg+!

mode of delivery is of minor importance, suggesting it’s not about the blood exposure?

the baby should receive passive and active vaccination immediately (this is super effective)

the mother should be given tenofovir in the last trimester if there is a high viral load

23
Q

is there any role for Hep B treatment in a patient about to receive immune suppression? (for example, about to undergo an HSCT or R-CHOP)

A

loss of immune control causes viral reactivation due to persistence of the cccDNA

then, when there is immune restoration, this can leads to a reconstitution illness (severe T cell mediated hepatitis)

at risk patients should have preemptive treatment with an anti-viral drug

24
Q

what is the Hep D virus?

A

this is a co-infection with chronic HBV

it is a defective DNA virus that uses the HBV viral polymerase to replicate

there’s not very much in way of treatment although some people have tried PEG-interferon

25
Q

in treatment of HCV with interferon alfa, what is most predictive of poor treatment response?

viral genotype
pre-treatment ALT
presence of cirrhosis
age of patient
plasma HCV RNA load
A

cirrhosis is slightly stronger than genotype from this list

26
Q

The best serological marker of an acute exacerbation (immunologic flare) of chronic hepatitis B is:

A. hepatitis B surface antigen.
B. hepatitis B e antigen.
C. hepatitis B e antibody.
D. hepatitis B surface antibody.
E. hepatitis B core IgM.
A

E is the answer here

?i thought ALT might be the best, but it’s not a “serological” marker apparently

27
Q

Which of the following factors is the strongest contraindication to the use of interferon in the treatment of viral hepatitis:

A. disease acquisition during childhood.
B. Child-Pugh category C status.
C. serum alanine transaminase levels

A

immunocompromised is a relative contraindication because you won’t get any response from the interferon

serum ALT

28
Q

what is hepatitis E?

A

it is an enteric virus that works a lot like hep A

very bad news for pregnant women

acute self-limiting usually